The Medical Minute: Solitaire for stroke -- It's not a game

May 22, 2012 By Kevin M Cockroft

Stroke is the fourth leading cause of death in North America -- down from third. Despite this "improvement," stroke remains the leading cause of adult disability. Ischemic strokes, caused by blood vessel blockages, are by far the most common type of stroke. For ischemic strokes, early intervention is crucial. The only drug FDA approved for the treatment of ischemic stroke is tissue plasminogen activator (tPA). Unfortunately, this drug must be given very soon after stroke onset, within the first three hours for most people and up to four and a-half hours for some.

The Solitaire device, produced by Covidien Inc. of Irvine, Calif., is the first of a new class of devices called stent-retrievers to be approved in the United States for the treatment of . Devices like Solitaire, which mechanically break up and remove clots, can be used up to eight hours or longer after a stroke, thus increasing the time window for patients to be treated.

Unlike the first generation retrieval devices, Solitaire is relatively easy to use and has a high success rate at opening blocked arteries. The device uses a retrievable basket-like stent to capture the clot, allowing it to be pulled from the blocked vessel. Patients suffering a stroke from a large artery blockage tend to make a much better recovery if the vessel is reopened than if the blockage is left in place or cannot be removed. Penn State Hershey Medical Center is the first and only hospital in this region to have access to this new, innovative device.

Despite advances in the treatment of stroke, many patients still do not make it to the hospital early enough to benefit from these advances. It is important for patients to remember the of stroke:

-- sudden weakness of the face, arm or leg;
-- sudden difficulty speaking or understanding speech; and
-- a sudden, very severe headache.

The sooner patients get medical attention the more treatment options they will have and the more likely it will be that they will receive a beneficial stroke treatment. Even though it may not hurt, a stroke is a medical emergency where minutes matter early on, for both initial treatment and future recovery.

Explore further: Clot-busting drug safe for stroke patients taking blood thinner

Related Stories

Clot-busting drug safe for stroke patients taking blood thinner

May 10, 2012
Acute ischemic stroke patients taking the blood thinner warfarin can be treated safely with the clot-busting drug tissue plasminogen activator (tPA), according to research presented at the American Heart Association's Quality ...

Use of clot busters for stroke increased from 2005 to 2009, but still low

June 2, 2011
The use of clot-busting drugs to treat acute ischemic stroke increased from 2005 through 2009 — but is still low, according to research reported in Stroke: Journal of the American Heart Association.

New device performs better than old for removing blood clots

February 3, 2012
An experimental blood clot-removing device outperformed the FDA-approved MERCI; retriever device, according to late-breaking science presented at the American Stroke Association's 2012 International Stroke Conference.

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.